Home/Bio Usawa Biotechnology/Patrick Lukulay, PhD
PL

Patrick Lukulay, PhD

Chief Operating Officer & Chief Regulatory Officer

Bio Usawa Biotechnology

Therapeutic Areas

Bio Usawa Biotechnology Pipeline

DrugIndicationPhase
Rituximab BiosimilarNon‑Hodgkin LymphomaPreclinical
Trastuzumab BiosimilarHER2‑Positive Breast CancerPreclinical
Bevacizumab BiosimilarVarious Solid TumorsPreclinical